Literature DB >> 9283240

Cyclosporine and tacrolimus.

S L Vaden1.   

Abstract

Cyclosporine and tacrolimus are potent immunosuppressant agents that have been used extensively in humans, primarily for prevention of transplant rejection but also for the treatment of autoimmune disorders. Both agents have similar mechanisms of action and pharmacokinetic profiles. However, the expected toxicity of the agents is dissimilar. Although cyclosporine usage in veterinary medicine is limited, it has been used enough for therapeutic guidelines to be established. Tacrolimus, however, has undergone limited use in veterinary medicine. The drug is too toxic in dogs for its use to be recommended in most clinical situations. This article reviews the mechanism of action, pharmacokinetics, expected drug interactions and toxicities, and clinical usage of cyclosporine and tacrolimus in veterinary medicine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9283240     DOI: 10.1016/s1096-2867(97)80028-x

Source DB:  PubMed          Journal:  Semin Vet Med Surg (Small Anim)        ISSN: 0882-0511


  2 in total

Review 1.  Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis.

Authors:  Tim Nuttall; Douglas Reece; Elizabeth Roberts
Journal:  Vet Rec       Date:  2014-03       Impact factor: 2.695

2.  Safety, tolerability, and pharmacokinetics of 6-month daily dosing of an oral formulation of cyclosporine (ATOPICA for cats®) in cats.

Authors:  E S Roberts; K A Vanlare; G Strehlau; M Peyrou; L M Roycroft; S King
Journal:  J Vet Pharmacol Ther       Date:  2013-10-18       Impact factor: 1.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.